INDRAPRASTHA MEDICAL CORPORATION Financial Statement Analysis
|
||
|
The Revenues of INDRAPRASTHA MEDICAL CORPORATION have increased by 9.30% YoY .
The Earnings Per Share (EPS) of INDRAPRASTHA MEDICAL CORPORATION has increased by 14.07 % YoY. |
||
INDRAPRASTHA MEDICAL CORPORATION Last 5 Annual Financial Results
[BOM: 532150|NSE : INDRAMEDCO]
| Standalone | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Operating Income | ₹1,483 Cr | ₹1,356 Cr | ₹1,245 Cr | ₹1,099 Cr | ₹888 Cr |
| Expenses | ₹1,216 Cr | ₹1,112 Cr | ₹1,051 Cr | ₹948 Cr | ₹774 Cr |
| Operating Profit (Excl OI) | ₹267 Cr | ₹244 Cr | ₹193 Cr | ₹151 Cr | ₹114 Cr |
| Other Income | ₹29 Cr | ₹23 Cr | ₹17 Cr | ₹10 Cr | ₹3.12 Cr |
| Interest | ₹6.02 Cr | ₹6.27 Cr | ₹4.06 Cr | ₹4.28 Cr | ₹3.41 Cr |
| Depreciation | ₹44 Cr | ₹44 Cr | ₹40 Cr | ₹39 Cr | ₹35 Cr |
| Profit Before Tax | ₹246 Cr | ₹216 Cr | ₹166 Cr | ₹117 Cr | ₹79 Cr |
| Profit After Tax | ₹184 Cr | ₹161 Cr | ₹124 Cr | ₹86 Cr | ₹59 Cr |
| Earnings Per Share (Rs) | ₹20.03 | ₹17.56 | ₹13.52 | ₹9.40 | ₹6.39 |
| PAT Margin (%) | 12.39 | 11.87 | 9.96 | 7.84 | 6.60 |
| ROE(%) | 27.47 | 29.97 | 28.92 | 24.44 | 19.60 |
| ROCE(%) | 37.70 | 41.43 | 39.70 | 34.46 | 27.58 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 3,224.6 Cr |
| Revenue (TTM) | : | ₹ 1,523.6 Cr |
| Net Profit(TTM) | : | ₹ 188.0 Cr |
| EPS (TTM) | : | ₹ 20.5 |
| P/E (TTM) | : | 17.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INDRAPRASTHA MEDICAL CORPORATION | -1.7% | -7.8% | -23.3% |
| APOLLO HOSPITALS ENTERPRISE | -0% | -2.5% | 12.8% |
| MAX HEALTHCARE INSTITUTE | -1.6% | -7.7% | -15.2% |
| FORTIS HEALTHCARE | -0.3% | -5.4% | -2.1% |
| ASTER DM HEALTHCARE | 4.9% | -8.6% | 24.2% |
| NARAYANA HRUDAYALAYA | -1.4% | 1.4% | 5.2% |
| GLOBAL HEALTH | -2.4% | -2.3% | 5.8% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 0.8% | -5.7% | 3.8% |
| DR LAL PATHLABS | -0.1% | -1.5% | 16.1% |
INDRAPRASTHA MEDICAL CORPORATION Revenues
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 9.30 % |
| 5 Yr CAGR | 13.66 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,483 Cr | 9.30 | |
| Mar2025 | ₹1,356 Cr | 8.97 | |
| Mar2024 | ₹1,245 Cr | 13.29 | |
| Mar2023 | ₹1,099 Cr | 23.70 | |
| Mar2022 | ₹888 Cr | - | |
INDRAPRASTHA MEDICAL CORPORATION Operating Profit
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 9.27 % |
| 5 Yr CAGR | 23.62 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹267 Cr | 9.27 | |
| Mar2025 | ₹244 Cr | 26.33 | |
| Mar2024 | ₹193 Cr | 28.31 | |
| Mar2023 | ₹151 Cr | 31.85 | |
| Mar2022 | ₹114 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -0.06 % |
| 5 Yr CAGR | 8.75 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 18% | -0.06 | |
| Mar2025 | 18.01% | 15.97 | |
| Mar2024 | 15.53% | 13.19 | |
| Mar2023 | 13.72% | 6.60 | |
| Mar2022 | 12.87% | - | |
INDRAPRASTHA MEDICAL CORPORATION Profit After Tax
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 14.06 % |
| 5 Yr CAGR | 33.04 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹184 Cr | 14.06 | |
| Mar2025 | ₹161 Cr | 29.87 | |
| Mar2024 | ₹124 Cr | 43.89 | |
| Mar2023 | ₹86 Cr | 46.96 | |
| Mar2022 | ₹59 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 4.38 % |
| 5 Yr CAGR | 17.05 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 12.39 % | 4.38 | |
| Mar2025 | 11.87 % | 19.18 | |
| Mar2024 | 9.96 % | 27.04 | |
| Mar2023 | 7.84 % | 18.79 | |
| Mar2022 | 6.6 % | - | |
INDRAPRASTHA MEDICAL CORPORATION Earnings Per Share (EPS)
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | 14.07 % |
| 5 Yr CAGR | 33.06 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹20 | 14.07 | |
| Mar2025 | ₹18 | 29.88 | |
| Mar2024 | ₹14 | 43.83 | |
| Mar2023 | ₹9.40 | 47.10 | |
| Mar2022 | ₹6.39 | - | |
INDRAPRASTHA MEDICAL CORPORATION Return on Capital Employed (ROCE)
[BOM: 532150|NSE : INDRAMEDCO]
| Y-o-Y | -9.00 % |
| 5 Yr CAGR | 8.13 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 37.7% | -9.00 | |
| Mar2025 | 41.43% | 4.36 | |
| Mar2024 | 39.7% | 15.21 | |
| Mar2023 | 34.46% | 24.95 | |
| Mar2022 | 27.58% | - | |
INDRAPRASTHA MEDICAL CORPORATION Share Price vs Sensex
| Current Share Price | : | ₹351.7 |
| Current MarketCap | : | ₹ 3,224.6 Cr |
| Updated EOD on | : | Sep 07,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDRAPRASTHA MEDICAL CORPORATION | -1.7% |
-7.8% |
-23.3% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
INDRAPRASTHA MEDICAL CORPORATION related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HOSPITALS | -0.5% | -3.4% | NA |
| BSE HEALTHCARE | -0.6% | 0.6% | 17.1% |
| BSE 1000 | -1% | -2.2% | 2.4% |
You may also like the below Video Courses
FAQ about INDRAPRASTHA MEDICAL CORPORATION Financials
How the annual revenues of INDRAPRASTHA MEDICAL CORPORATION have changed ?
The Revenues of INDRAPRASTHA MEDICAL CORPORATION have increased by 9.30% YoY .
How the Earnings per Share (EPS) of INDRAPRASTHA MEDICAL CORPORATION have changed?
The Earnings Per Share (EPS) of INDRAPRASTHA MEDICAL CORPORATION has increased by 14.07 % YoY .
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs FORTIS HEALTHCARE LTD
ASTER DM HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs